Intra-abdominal pressure reflects the bladder pressure or pressure inside the abdominal compartment and is usually measured via a urinary catheter. It is used to identify the risk of intra-abdominal hypertension (IAH) and abdominal compartment syndrome (ACS). The condition associated with this syndrome is major fluid resuscitation, severe gut edema or intestinal obstruction or ascites. Normal intra-abdominal pressure is 0 - 5 mmHg.
The global intra-abdominal pressure measurement devices market is estimated to account for US$ 201.9 Mn in terms of value by the end of 2027.
Browse Summary of the Research Report- https://www.coherentmarketinsights.com/market-insight/intra-abdominal-pressure-measurement-devices-market-3514
Development of Di-(2-ethylhexyl) phthalate (DEHP)-free products is expected to propel growth of the global intra-abdominal pressure measurement devices market over the forecast period. DEHP is commonly used in the medical devices industry as a plasticizer for various plastic materials to make plastic flexible. Use of these phthalates in the device/disposable manufacturing process may inhibit testosterone production in the adult human testis and affect reproductive health. Therefore, market players are focused on offering alternatives to DHEP such as DEHT (Di-(2-ethylhexyl) terephthalate), which is not genotoxic and does not cause reproductive toxicity. For instance, ConvaTec Inc. offers its major continence & critical care brands that are DEHP-free. This includes the flexi-seal fecal management system and the abviser autovalve intra-abdominal pressure monitoring devices.
Moreover, increasing incidence of trauma cases is also expected to aid in growth of the market. For instance, according to January 2018 factsheet of the World Health Organization, 20–30% of older people who fall suffer moderate to severe injuries such as bruises, hip fractures, or head trauma, in the U.S.North America region held dominant position in the global intra-abdominal pressure measurement devices market in 2019, accounting for 57.2% share in terms of value, followed by Europe.
Complications associated with the procedures are expected to hinder growth of the global intra-abdominal pressure measurement devices market. Intra-abdominal pressure is generally measured via a patient’s bladder. Some of the major problems associated with pressure management devices include bladder infection and needle stick injuries that may cause patient discomfort and raise compliance risks.Although there have been several publications in the recent past, IAP measurement techniques and clinical applicability have not been fully established to date. Intravesical IAP measurement is a consensus. However, there are challenges regarding zero-reference point, infusion volume, measurement frequency, and indications. Such scenario is also expected to hinder growth of the market.
Tapping into markets in Asia Pacific, Latin America & GCC countries is expected to create significant market opportunity for players in the target market over the forecast period. Moreover, increasing prevalence of chronic diseases and rising ICU admissions, owing to traumatic injuries in emerging economies is expected to drive overall market growth of the market. For instance, according to the Ministry of Road Transport and Highways, Government of India, in 2018, the number of road accidents increased by 0.46% compared to 2017. Moreover, increasing awareness regarding intra-abdominal pressure measurement or compartment pressure measurement among healthcare professionals is also expected to aid in growth of the market. Continuous Medical Educations and training sessions on usage and significance of intra-abdominal pressure measurement could improve sales of a company offering intra-abdominal pressure products.
Disposables product segment in the global intra-abdominal pressure measurement devices market was valued at US$ 53.1 Mn in 2019 and is expected to reach US$ 182.7 Mn by 2027 at a CAGR of 16.7% during the forecast period.The market is witnessing increasing shift from physical measurement to clinical measurement. Conventionally, physicians relied on physical or visual detection of signs of intra-abdominal hypertension. However, several intensive care physicians are preferring clinical examination of intra-abdominal hypertension over physical detection, owing to better sensitivity and accuracy.
Patients in the intensive care unit (ICU) are at risk of developing of intra-abdominal hypertension (IAH) and abdominal compartment syndrome (ACS). However, effective management of IAH and ACS can reduce duration of ICU stay, which in turn can decrease healthcare expenditure.
Major players operating in the global intra-abdominal pressure measurement devices market include, C. R. Bard, Inc. (Becton, Dickinson and Company), ConvaTec Group PLC, Stryker Corporation, Biometrix Ltd.(Degania Silicone, Ltd.), Centurion Medical Products (Medline Industries, Inc.), Holtech Medical, and Potrero Medical.
Major players in the market are focused on product approval and launch to expand their product portfolio. For instance, in July 2019, Potrero Medical received CE mark in the European Union for its technology platform, the Accuryn Monitoring System that transforms the traditional indwelling urinary catheter into a next-generation diagnostic tool for precise, real-time measurement of intra-abdominal pressure.
Request A Sample Copy - https://www.coherentmarketinsights.com/insight/request-sample/3514
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Email: [email protected]